MMP14 and obesity due to melanocortin 4 receptor deficiency: In sum, we have demonstrated an inter-organ and hepatocyte-intrinsic dual inflammatory and metabolic function for MMP14 that is pharmacologically modifiable, and we provide novel agents with which to achieve MMP14 targeting to potentially abate obesity and its complications.